TotalEnergies与中石化合作，每年生产23万吨可持续航空燃料
这两家公司都专注于低碳解决方案，其中TotalEnergies的目标是到2030年实现150万吨可持续航空燃料(SAF)的生产。作为欧洲领先的SAF生产商之一，TotalEnergies将在技术、运营和分销领域贡献其经验和专业知识。
Update: Rheinmetall Receives €130 Million EU Funds To Produce 155mm Artillery Ammunition and Powder Across Europe
Rheinmetall received over €130 million in EU funds to boost artillery production across Europe.
Update: 142 Natural Catastrophes in 2023 led to $108 Billion Insured Losses
A devastating earthquake in Turkey and Syria, severe convective storms (SCS) and large-scale urban floods were the main events driving insured natural catastrophe…
Update: Deutsche Telekom Wants to Reach Climate Neutrality by 2040
Initiatives include recycling mobile devices, promoting digital literacy, and supporting a circular economy.
Update: US Department of Energy Selects Heidelberg Materials For $500 Million Funding
Funding news for a large-scale carbon capture, transport, and storage (CCUS) project at Mitchell, Indiana cement plant.
Update: TotalEnergies and Sinopec Partner to Produce 230,000 tons of Sustainable Aviation Fuel Annually
TotalEnergies and SINOPEC partner to produce sustainable jet fuel at a SINOPEC refinery in China. The collaboration aims to develop a unit producing…
UBS Group AG To Redeem EUR 1,75 Billion In Senior Unsecured Notes
UBS Group AG plans to redeem EUR 1,750,000,000 Senior Fixed Rate/Fixed Rate Notes on April 17, 2024. The Notes were issued in 2018…
eActros 600 Passa Testes em Condições Extremas de Frio na Finlândia Antes do Lançamento da Produção
Rovaniemi, Finlândia – A Daimler Trucks anunciou na quinta-feira que completou testes críticos em condições de frio para seu inovador eActros 600, um…
Qiagen Launched Diagnostic Tool Promising A Game-Changer in Quick Disease Detection
QIAGEN launches QIAstat-Dx Analyzer 2.0 with remote results access, improving healthcare collaboration.
Update: FDA Approves Ultomiris for NMOSD
London, UK — AstraZenca Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor…